Cellectar Biosciences, Inc.
Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy

Last updated:

Abstract:

Disclosed herein are phospholipid ether (PLE) molecules. Further provided are phospholipid-flavagline conjugates. The phospholipid-flavagline conjugate may include a PLE conjugated to a flavagline via a linker. Further provided herein are methods of treating cancer in a subject and methods of targeting a drug to a tumor or cancer cell in a subject.

Status:
Application
Type:

Utility

Filling date:

10 Apr 2019

Issue date:

3 Jun 2021